These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 14839877
1. [Xanthic derivatives inhibiting the inversion by ergotamine of the hypotensor effects of isopropyladrenaline and of 3-4-dioxyephedrine]. HAZARD R, BEAUVALLET M, GIUDICELLI R. C R Seances Soc Biol Fil; 1951 Jan; 145(1-2):78-80. PubMed ID: 14839877 [No Abstract] [Full Text] [Related]
2. Interaction of ergotamine and carbon dioxide on blood pressure and respiration. LILJESTRAND A. Acta Physiol Scand; 1948 Apr 20; 15(2):198-206. PubMed ID: 18863143 [No Abstract] [Full Text] [Related]
3. [Effect of associated acetylcholine-atropine and acetylcholine-ergotamine on essential hypotension]. RIVASI P. Rass Neurol Veg; 1950 Jun 20; 8(2):138-49. PubMed ID: 14781409 [No Abstract] [Full Text] [Related]
4. Clinical observations on the mechanism of hypertensive headache and the results of its treatment with dihydro-ergotamine tartrate. BIRCHALL R, TAYLOR RD, PAGE IH. Cleve Clin Q; 1946 Oct 20; 13(4):227-31. PubMed ID: 20274028 [No Abstract] [Full Text] [Related]
5. [Research on the modifications brought by ergotamine to the vascular effects of isopropyladrenaline and adrenaline]. HAZARD R, BEAUVALLET M, GIUDICELLI R. Arch Int Pharmacodyn Ther; 1948 Nov 01; 77(4):504-8. PubMed ID: 18107053 [No Abstract] [Full Text] [Related]
7. The antiadrenolytic action of ergotamine. KING TO, KOPPANYI T. J Am Pharm Assoc Am Pharm Assoc; 1949 Jun 01; 38(6):346-8. PubMed ID: 18151713 [No Abstract] [Full Text] [Related]
8. [Effects of prolonged ergotamine therapy; clinical study of a case of ergotamine therapy abnormally prolonged without toxic complications]. SANGIORGI M. Riforma Med; 1951 Jan 06; 65(1):4-9. PubMed ID: 14816994 [No Abstract] [Full Text] [Related]
9. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. PETERS GA, HORTON BT. Proc Staff Meet Mayo Clin; 1951 Apr 25; 26(9):153-61. PubMed ID: 14827944 [No Abstract] [Full Text] [Related]
10. Experiments with dihydro-ergotamine. VAN DONGEN K, DE BOER J. Acta Brevia Neerl Physiol Pharmacol Microbiol E A; 1949 Apr 25; 17(1-4):39. PubMed ID: 15394593 [No Abstract] [Full Text] [Related]
12. [Clinical value of ergotamine tests in electrocardiography]. KISS A, SLAPAK L. Wien Z Inn Med; 1951 Apr 25; 32(4):162-7. PubMed ID: 14836723 [No Abstract] [Full Text] [Related]
15. Effects of adrenaline and ergotamine on the oxygen consumption. LUNDHOLM L, MOHME E. Acta Physiol Scand; 1949 Jan 22; 16(4):367-88. PubMed ID: 18128141 [No Abstract] [Full Text] [Related]
17. Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. PETERS GA, HORTON BT. J Lab Clin Med; 1950 Dec 22; 36(6):972-3. PubMed ID: 14795057 [No Abstract] [Full Text] [Related]
18. [Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results]. GIRARD M. Lyon Med; 1950 May 28; 183(22):345-8. PubMed ID: 15438042 [No Abstract] [Full Text] [Related]
20. [Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results]. GIRARD M. J Med Chir Prat; 1950 Aug 28; 121(8):165-9. PubMed ID: 24538126 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]